4Tajiri T, Onda M, Yoshida H,et al.Long term hematological and biochemical effects of partial sptenic embolization in hepatic cirrhosis[J].Hepatogastroenterology, 2002,49 : 1445.
5Nomura S, K azuo D,Tomomitsu H,et al.Effects of pegylated recombinan human megakaryoctcyte growth and development factor in patients with idiopathic thrombocytopenic purpura[J].Blood ,2002,100 (3):728.
6张之南,沈涕.血液病诊断及疗效标准[M].第2版.北京:科技出版社,2006:274.
7Tajiri T, Onda M, Yoshida H, et al.Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis[J]. Hepatogastroent, 2002, 49(47):1445-1448.
8Nomura S, K azuo D, Tomomitsu H, et al.Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura[J].Blood, 2002, 100(3): 728-730.
